Objective: Various cell adhesion molecules are expressed in atherogenesis and the significance of their involvement in atherosclerotic 21 lesion formation is well appreciated. In the present work, we examined whether the Ca -dependent cell adhesion molecule E-cadherin is also involved in atherogenesis. Methods: Specimens of carotid artery and aorta were obtained at operation. Expression of E-cadherin was studied by an immunohistochemical method. The nature of E-cadherin-expressing cells was examined by comparative analysis of consecutive sections and by a double immunostaining procedure. An immunohistochemical approach was also applied to examine how the accumulation of oxidised low density lipoproteins (LDL) by intimal cells is associated with E-cadherin expression. Results: No E-cadherin cells were found in normal non-atherosclerotic intima but E-cadherin cells were present in 96% of the atherosclerotic lesions. In atherosclerotic intima, E-cadherin was expressed by intimal cells showing varying degrees of transformation into foam cells.
Introduction
ICAM-1 and the selectins, as well as the development of mouse models with an increased susceptibility to atheroThe importance of leukocyte and endothelial cell adhesclerosis, promoted investigations on the role of inflammasion molecules (CAMs) in the formation of intercellular tory CAMs in the pathogenesis of atherosclerosis [7] . contacts has been widely appreciated [1] . Expression of These genetic based studies provided strong evidence that inflammatory CAMs such as ICAM-1, VCAM-1, P-selecthe level of expression of CAMs can determine susceptin, and E-selectin has been intensely studied in atherostibility to the formation of atherosclerotic lesions, while a clerotic lesions and the increased expression of various deficiency of inflammatory CAMs can protect against the inflammatory CAMs in atherogenesis is well documented development of atherosclerosis [7] . [2] [3] [4] [5] [6] . The availability of mice with mutations for CD18, Inflammatory CAMs responsible for heterotypical cellto-cell interactions have received considerable attention [1] [2] [3] [4] [5] [6] [7] , but CAMs determining mostly homotypical cell processed by standard formalin fixation and paraffin interactions have not yet been studied in human atheroembedding. Sections were cut at 5-mm thickness. For sclerosis or in models simulating human atherogenesis. In routine histology they were stained with haematoxylin and 21 the present work we investigated whether the Ca -depeneosin. dent cell adhesion molecule E-cadherin is expressed in normal and atherosclerotic human arteries. Our interest 2.2. Investigating E-cadherin expression was stimulated by studies indicating that E-cadherin is expressed by Langerhans cells which are part of the family E-cadherin antibody was purchased from Transduction of dendritic cells [8, 9] .
Laboratories (Lexington, KY, USA). Expression of EIn previous publications we reported that dendritic cells cadherin was examined in paraffin sections using a biotinreside in the intima of large arteries [10, 11] , that their streptoavidin kit (Nichirei, Tokyo) and a 3-amino-9-numbers increase in atherosclerotic lesions [11, 12] , and ethylcarbazole (AEC) substrate-chromogen system (Dako, that these vascular dendritic cells appear to be involved in Carpinteria, CA, USA) which results in the red staining of local immunoinflammatory reactions [13] . Vascular deantigens. After blocking endogenous peroxidase with 3% ndritic cells share many of the immunogenic and structural hydrogen peroxide in methanol for 20 min, microwave characteristics typical of other dendritic cells [10] [11] [12] [13] and pre-treatment in 10 mM citrate buffer (pH 6.0) for 10 min a subtype of vascular dendritic cells might relate to and treatment with normal horse serum for 30 min, Langerhans cells [14] . We were therefore interested to see sections were incubated with E-cadherin antibody in a 5 whether vascular dendritic cells express E-cadherin. mg / ml concentration for 45 min. The biotin-streptoavidin Using anti-E-cadherin antibody we found that Ekit, which included biotinylated anti-mouse antibody and cadherin is widely expressed in human atherosclerotic peroxidase-conjugated streptoavidin, was used according lesions. The present report describes the distribution of to the manufacturer's recommendations. The peroxidase-E-cadherin expression in the arterial wall and the characoxidase reaction was developed with the AEC substrate teristics of E-cadherin-positive cells.
kit. As an alternative method for identifying E-cadherin expression, Envision-labelled polymer reagent (Dako, Kyoto, Japan) was used prior to the application of the AEC 2. Methods substrate kit. All immunohistochemical procedures were performed at room temperature. Duodenum sections were 2.1. Tissue specimens and routine histology used for a positive control (Fig. 1A) . For negative controls, the first antibody was omitted or the sections were treated The material was collected in accordance with the with an immunoglobulin fraction of non-immune goat principles outlined in the Declaration of Helsinki [15] . serum used as a substitute for the primary antibody. None Arterial wall segments from 27 carotid arteries and 20 of the negative control sections showed positive immune aortas were obtained from patients whose ages ranged staining. Counterstaining was performed with Gill's from 35 to 67 years. The carotid specimens were obtained haematoxylin. Sections were examined in an Olympus by endarterectomy and the aortic specimens were collected microscope at 10310, 10320 and 10340 magnifications. during aortic reconstructions at St. Vincent's Hospital,
The frequency of E-cadherin-positive cells in different Sydney. The characteristics of this material were previousareas was estimated by semi-quantitative analyses. ly reported [11, 16] . Because the specimens were relatively large (up to 5 cm), it was possible to find different 2.3. Characterisation of cells expressing E-cadherin atherosclerotic lesions, including early lesions, in the same using sets of serial consecutive sections immunostained specimen. The arterial specimens also included part of the by single staining immunoperoxidase procedure adjacent normal-appearing arterial wall. According to their microscopic characteristics, the lesions were classified as The analyses were carried out using sets of consecutive diffuse intimal thickenings, fatty streaks, atheromatous paraffin sections immunostained with antibodies to Eplaques and complicated plaques as in our previous work cadherin and cell type specific antibodies to macrophages [11] .
(CD68, HAM56), smooth muscle cells (alpha-smooth For both routine histological examination and further muscle actin and human muscle actin), T-cells (CD3), immunohistochemical analysis, the arterial specimens were B-cells (CD20), endothelial cells (von Willebrand factor) and mast cells (CD15) ( antibodies, a double immunostaining technique was used. were identified with anti-o-LDL antibody (a kind gift of Differing combinations of antigens including E-cadherin / Dr. Franz Tatzber) which allowed the formalin fixation of CD68, E-cadherin / alpha-smooth muscle actin, E-cadherin / specimens and their routine embedding in paraffin [17] .
CD3 and E-cadherin / S-100 were analyzed using the The sources and working concentrations of antibodies approach previously described [18, 19] . The co-localisation used are given in Table 1 . The immunohistochemical of E-cadherin with o-LDL as well as the co-localisation of procedures used for identifying different cell types were o-LDL with CD68 macrophage-associated antigen were the same as described for E-cadherin identification. For also examined by double immunostaining. For double blocking endogenous peroxidase, 3% H O in methanol immunostaining, staining with the first primary antibody 2 2 for 20 min was applied. To prevent lipid peroxidation in was performed using the same protocol as described above tissue sections in which the distribution of o-LDL was for a single immunostaining procedure. After visualisation studied, the sections were pre-treated with 0.3% H O in of the first primary antibody with the AEC substrate kit, 2 2 PBS containing 0.5 mM butylated hydroxytoluene (Sigma) the slides with the tissue sections were washed several for 10 min to block endogenous peroxidase. Pre-treatment times during 60 min with 0.1 M glycine-hydrochloric of the sections with trypsin and microwave boiling in buffer (pH 2.2) at 48C. The sections were then treated, if citrate buffer were used when necessary as indicated in necessary (Table 1) , with 0.1% trypsin at 458C for 30 min Table 1 . Comparison of the stained consecutive sections or a microwave pre-treatment in 10 mM citric buffer (pH enabled the characteristics of E-cadherin-positive cells to 6.0) was applied for 10 min. The sections were further be investigated and their cell nature to be determined. The incubated overnight at 48C with one of the second primary same intimal areas were selected in consecutive sections, antibodies. After rinsing in PBS, the sections were incuand the numbers of cells expressing two different antigens bated with an appropriate, anti-mouse or anti-rabbit were estimated at a magnification of 3400. The numbers biotinylated antibody (Nichirei, Tokyo) for 12 h at 48C. of cells which displayed both antigens were expressed as a After washing in PBS, the sections were incubated at room percentage of the total number of cells expressing only one temperature with alkaline phosphatase-conjugated strepof either antigens.
toavidin (Nichirei, Tokyo) for 30 min, and the reaction was then visualised with fast blue substrate kit (Nichirei, exhibited signs of transformation into foam cells and some Tokyo). The double immunostaining procedure used for had the appearance of typical foam cells ( Fig. 1 
B-D). identifying antigens located in the same cells could give
In different types of atherosclerotic lesions, numerical false negative results because visualisation of the first differences in E-cadherin expression were apparent beantigen can preclude visualisation of the second antigen.
tween different layers of the intima within the wall of the Therefore, the sequence of applying the first and second same vessel as well as between different zones of the same primary antibodies was reversed. Negative controls were layers. Within atherosclerotic plaques, the areas containing performed as described above. None of the negative E-cadherin-positive cells bordered on areas which were control sections showed positive immune staining.
free from E-cadherin expression. Furthermore, within the same plaques but in different areas containing E-cadherinpositive cells, the numbers of these E-cadherin-positive cells were found to vary from less than 1% up to 80% 3. Results when microscopic fields were examined at a magnification of 3400. The variations in the extent of E-cadherin 3.
E-cadherin expression in atherosclerotic arterial
expression cannot be related to the age of the patient or the wall duration of disease as within the same arterial segments there were intimal areas with different extents of E-E-cadherin-positive cells were detected in 96% of cadherin expression. atherosclerotic lesions taken from the aortas and carotid
Because the density and numbers of E-cadherin-positive arteries but no E-cadherin expression was found in normal cells varied considerably between different areas of the non-atherosclerotic intima (Table 2 ). In all the specimens, same lesion and because there were marked variations in the media adjacent to non-atherosclerotic intima was also the numbers and the distribution of E-cadherin-positive free of E-cadherin expression. In some segments of cells between specimens obtained from different indiatherosclerotic wall adjacent to plaques, E-cadherin-posividuals, we avoided estimating the precise overall numbers tive cells were detected in the media but no E-cadherinof E-cadherin-expressing cells in different lesions. We positive cells were found in the aortic adventitia (Table 2) .
have, however, estimated the relative frequency of EThe patterns of E-cadherin expression in carotid artery cadherin-expressing cells in different areas of several types specimens were similar to those in aortic specimens. In the of atherosclerotic lesions (Table 3) . In intimal thickenings, atherosclerotic lesions, almost all E-cadherin-positive cells the distribution of E-cadherin-positive cells was uneven with the highest proportion of E-cadherin-positive cells cells were recognised. Type I E-cadherin-positive cells located in the middle and deeper sublayers. E-cadherinwere represented by elongated, spindle-like cells which positive cells were more regularly distributed in fatty typically, were longitudinally orientated along the arterial streaks than in atherosclerotic plaques. In atheromatous lumen (Fig. 1B, C) . The numbers of lipid vacuoles in their plaques, the external parts of the lipid core were always cytoplasm varied markedly, although cells containing only rich in E-cadherin expression unlike the central parts in a few lipid vacuoles were prevalent (Fig. 1B, C) . Type II which E-cadherin expression was sparse. In plaques, the E-cadherin-positive cells were represented by round, oval fibrous caps showed the lowest proportion of E-cadherinor irregularly shaped cells usually containing a large expressing cells. In complicated atherosclerotic plaques, number of lipid vacuoles (Fig. 1D) . In some of these, the the areas of neovascularisation with large numbers of cytoplasm was completely filled by vacuoles (Fig. 1D ). inflammatory cells were always poor in E-cadherin expres-
The incidence of different micro-patterns of these cells in sion while the areas of neovascularisation which lacked the same types of atherosclerotic lesions were similar inflammatory cells showed variable E-cadherin expression.
between the carotid and aortic specimens (Table 3) . In all the atherosclerotic lesions studied, three common
The intensity of E-cadherin immunostaining in different micro-patterns of distribution of E-cadherin-positive cells intimal cells varied (Fig. 1B-D) . When the intensity of were identified: (i) isolated scattered E-cadherin-positive E-cadherin staining of duodenal epithelium was used for cells (Fig. 1B) ; (ii) small clusters consisting of 2 to 4 comparison (Fig. 1A) , in more than 70% of all E-cadherin E-cadherin-positive cells (Fig. 1C) ; and (iii) aggregates of intimal cells, the intensity of the staining was found to be E-cadherin-positive cells of different sizes (Fig. 1D) . The stronger, equal to, or approaching that of duodenal epi-E-cadherin-positive cells were of different shapes and, thelium. In different atherosclerotic lesions, 45% to 60% of from their appearance, two types of E-cadherin-positive all E-cadherin-positive cells expressed E-cadherin more
Fig. 2. E-cadherin expression and accumulation of o-LDL in atherosclerotic lesions (A-F). (A) and (D) represent the patterns of E-cadherin expression in a fatty streak (A) and an atherosclerotic plaque (D), while (B) and (E) show the patterns of accumulation of o-LDL (A and B as well as D and E are sets of consecutive sections). (F) represents a negative control which was produced in the section consecutive to that shown in (E). (C)
shows the typical appearance of E-cadherin-positive cells in fatty streaks. Immunoperoxidase technique; visualisation of E-cadherin expression (red) was produced with AEC substrate kit; counterstaining was with Gill's haematoxylin. Original magnifications: 3100, 3100, 3400, 3100, 3100, 3100.
Fig. 3. Double immunostaining demonstrating the association of the accumulation of o-LDL with E-cadherin expression in foam cells located separately (A, B) and in a massive group (C). In (A) and (B)
, o-LDL were visualised with AEC substrate kit (red product of reaction), (small arrows) while E-cadherin immunostaining was produced with a Fast Blue substrate kit (blue product of reaction) (large arrows). Note that these foam cells contain both E-cadherin and o-LDL. Note also that o-LDL are present in the extracellular matrix where they are irregularly distributed. In (C), E-cadherin expression was visualised with AEC substrate kit (red) while the location of o-LDL was identified using a Fast Blue substrate kit (blue). E-cadherin and o-LDL are irregularly distributed in the cytoplasm of foam cells. Some cytoplasmic areas contain a violet coloured product resulting from the combination of red and blue colours. A few cells containing o-LDL are E-cadherin negative (blue). Original magnifications: 3400, 3400, 3400.
streaks, E-cadherin-positive foam cells constituted up to strongly than duodenum epithelium. Many weakly E-80% of the total number of foam cells. In general, the cadherin-positive cells showed ill-defined contours (Fig. proportion of E-cadherin-positive foam cells in plaques 1D) and virtually all of them were seen to locate in cell was lower than in fatty streaks. Mosaic clusters containing aggregates or in the lipid core.
both E-cadherin-positive and E-cadherin negative foam Almost all E-cadherin-positive intimal cells showed cells were also seen in fatty streaks and in plaques. In signs of transformation into foam cells but not all foam different areas of the same plaque, differing numbers of cells expressed E-cadherin. The proportion of E-cadherinfoam cells expressed E-cadherin. In the outer parts of the expressing cells in the total foam cell population was lipid core, 20% to 80% of foam cells expressed Eestimated by examination at magnification 3400. In fatty cadherin. In the central part of the lipid core, 70% to 100% formation into foam cells were negative for E-cadherin. of foam cells were E-cadherin negative. Most of these Double immunostaining confirmed the co-localisation of E-cadherin negative cells had pyknotic nuclei and showed CD68 macrophage-associated antigen with E-cadherin in ill-defined contours consistent with cell destruction. the same cells (Fig. 5A, B) . In the lipid core, E-cadherinexpressing foam cells usually showed weak immuno-3.2. E-cadherin expression versus oxidised LDL positivity for CD68 (Fig. 5A) while separately located accumulation E-cadherin-positive foam cells contained significant amounts of CD68 macrophage-associated antigen (Fig.  Single immunostaining showed an association between 5B). In some lesions, the extent of E-cadherin expression E-cadherin expression and foam cell formation. We theremarkedly exceeded the expression of CD68 (Fig. 5C, D) . fore compared the patterns of E-cadherin expression with Analyses of serial sections indicated that neither smooth the patterns of accumulation of o-LDL. When the antibody muscle cells nor foam cells of smooth muscle cell origin 1 against o-LDL (anti-o-LDL) was applied, two patterns of (alpha-smooth muscle actin ) were positive for E-cadherin specific immunostaining, namely, extracellular and in-( Fig. 4A, C; Fig. 5C, F; Fig. 6A, B) . Using double tracellular, were identified in the atherosclerotic lesions.
immunostaining we were not able to identify any cells Staining of the extracellular matrix was usually weak and simultaneously expressing alpha-smooth muscle actin and the areas of anti-o-LDL immunopositivity were irregularly E-cadherin (Fig. 6D ). In the areas where E-cadherin foam distributed throughout the atherosclerotic intima. In concells were present, the networks formed through smooth trast, anti-o-LDL positive cells mostly exhibited intense muscle cell processes were destroyed. specimens have been previously reported [11] . The present Analysis of serial sections stained with E-cadherin examination showed that only about 1 in 50 S-100-positive antibody and anti-o-LDL demonstrated that in many areas cells expressed E-cadherin and this expression was always 1 1 of atherosclerotic intima, the patterns of distribution of weak. Some E-cadherin / S-100 cells were detected in both markers were similar, or even almost identical, but the media (Fig. 7) . the extent of the accumulation of o-LDL was usually larger
The comparison of consecutive sections stained for CD3 1 than that of E-cadherin expression (Fig. 2) . Comparison of and E-cadherin indicated that T-cells (CD3 ) did not serial sections showed that virtually all E-cadherin-positive express E-cadherin (Fig. 5C, E) . When double immunocells contained o-LDL in their cytoplasm. Double imstaining was applied, we also failed to detect the comunostaining confirmed that E-cadherin expression colocalisation of E-cadherin with CD3. Luminal endothelial existed with the accumulation of o-LDL in the cytoplasm cells as well as the endothelium of neovascularisation (von 1 of foam cells but some foam cells containing o-LDL were Willebrand factor ) were found to be negative for E-1 free of E-cadherin expression (Fig. 3A-C) . cadherin. In atherosclerotic lesions, mast cells (CD15 ) were seen as less than 1% of the total cell population and 
Examination of the nature of E-cadherin-expressing
were found to be negative for E-cadherin. B-cells (CD20 ) cells were very seldom detected and we failed to find any B-cells expressing E-cadherin. In some intimal areas, the patterns of CD68 positivity, A comparison of consecutive sections stained for E-E-cadherin expression and o-LDL accumulation were cadherin and cell type-specific markers showed that in all 1 similar (Fig. 4A, B, D) . Differing numbers of CD68 the specimens, 40% to 85% of all E-cadherin-positive cells foam cells (15% to 60%) expressed E-cadherin. However, did not stain with any cell type-specific markers including 1 all CD68 macrophages which showed no signs of transmarkers to macrophages, smooth muscle cells, endothelial Immunostaining for E-cadherin, smooth muscle alpha-actin, and CD68 in a fatty streak in a carotid artery (A-D). Staining for E-cadherin (A), smooth muscle alpha-actin (B) and CD68 (C) produced in consecutive sections shows that in this fatty streak, the distribution of E-cadherin is different from that of smooth muscle cells and that macrophages are absent. (A-C) Immunoperoxidase technique; visualisation of E-cadherin expression (red) was produced with AEC substrate kit; counterstaining was with Gill's haematoxylin. (D) shows double immunostaining for smooth muscle alpha-actin (red) and E-cadherin (blue). Smooth muscle alpha-actin was visualised with AEC substrate kit and E-cadherin immunostaining was produced with the Fast Blue substrate kit. Note that smooth muscle cells are E-cadherin negative. Original magnifications: 3100, 3100, 3100, 3400. in the development of atherosclerotic lesions [2, 5, 29] and the identification of cell adhesion molecules which are specifically associated with lipid transformation of intimal 4. Discussion cells would assist in understanding the mechanisms involved.
E-cadherin: a new marker for atherosclerotic
The present study did not establish the functions of alteration of the arterial wall E-cadherin expression in atherogenesis but our observations that E-cadherin is expressed by scattered cells The expression of E-cadherin is developmentally regcontaining a few lipid vacuoles as well as by clustered ulated [20] [21] [22] . In adults, E-cadherin expression is refoam cells in the early stages of lesion development might quired for normal epithelial functions [20] [21] [22] . E-cadherin imply that E-cadherin is important for foam cell aggregaappears to be involved in a much wider spectrum of tion. If E-cadherin is involved in foam cell aggregation, it cell-to-cell interactions than was thought when E-cadherin might be also involved in the development of the lipid was designated as epithelial (E)-cadherin [21, [23] [24] [25] [26] . In core. the last decade, E-cadherin has been intensively studied, Elucidating how foam cells selectively adhere to each especially because the loss of E-cadherin has been attribuother is an important issue for understanding lipid core ted to a pathogenic role in tumour invasion [21, [26] [27] [28] .
formation, itself a crucial event in the progression of early Our observation that E-cadherin is expressed by intimal atherosclerotic lesions [5, 30, 31] . Morphological observacells transforming into foam cells suggests an even broader tions indicate that the formation of the lipid core is involvement of E-cadherin in pathological processes.
associated with the accumulation and aggregation of foam The observations that E-cadherin is not expressed in cells in the deep layers of the intima [30, 31] . The present normal non-atherosclerotic intima and that patterns of its observations of intense expression of E-cadherin by foam expression are different in different types of atherosclerotic cells forming clusters in early atherosclerotic lesions might lesions suggest that E-cadherin is involved in the formation suggest that E-cadherin is important for foam cell coheand progression of lesions. In atherosclerotic intima, Esion. Studies on embryogenesis and in vitro experiments cadherin expression is mostly restricted to cells transformindicate that the switching on and off of E-cadherin ing into foam cells. All E-cadherin-positive cells (excludexpression correlates with a variety of morphological events involving cell aggregation or disaggregation, and bility. However, only some of the E-cadherin-positive cells that closely aggregating cells show greater E-cadherin looked like mature foam cells while many others contained expression than non-aggregating cells [20, 21, 27, 28] . The only a few lipid vacuoles in their cytoplasm. This implies expression of E-cadherin by forming and mature foam that the shedding of cell type specific markers during cells might also indicate that their motility is diminished transformation of intimal cells into foam cells cannot be which further facilitates cellular aggregation since in exclusively responsible for the appearance of E-cadherinembryogenesis, the downregulation of cell migration depositive cells which did not co-label with any cell type pends on E-cadherin expression [20] [21] [22] .
specific marker in the present study. In the present study, a high variability in the expression
The presence of undefined cell types in human atherosof E-cadherin was found in atheromatous plaques.
clerotic lesions which do not mark with cell type-specific Atheromatous plaques are characterised by widespread antibodies such as HHF35 (smooth muscle cells), HAM-56 destruction of intimal cells, in particular, foam cells in and (macrophages) or antibodies to CD45 (lymphocytes) or around the lipid (necrotic) core [31] [32] [33] [34] . According to our factor VIII related antigen (endothelium) has been previobservations, loss of E-cadherin expression relates to foam ously reported [38, 39] and these unidentified cells have cell destruction in atheromatous plaque.
been referred to as mesenchymal-appearing intimal cells [39] or null cells [38] . In some arterial specimens, null 4.2. Nature of E-cadherin-expressing cells in cells expressing ICAM-1 comprised approximately 50% of atherosclerotic lesions all ICAM-1-expressing cells [38] . We earlier speculated that some null cells might be vascular dendritic cells [40] . E-cadherin was found to be expressed by different cell
The present investigation, however, shows that apart from types. Firstly, some foam cells of macrophage origin smooth muscle cells, macrophages, endothelial cells, Tdisplayed E-cadherin. We are not aware of other work cells, vascular dendritic cells, mast cells and B-cells, showing that macrophages express E-cadherin either in another cell type does reside in the intima and represents a adults or in embryogenesis, or under pathological consignificant proportion of the E-cadherin-positive cell popuditions. E-cadherin, however, was not expressed by those lation. The origin and nature of the E-cadherin-positive macrophages in which there were no signs of transformanull cell population requires further clarification. tion into foam cells. This finding might suggest the pathological activation of the E-cadherin gene in macrophages transforming into foam cells. We speculate that this
